Skip to main content

Caris Life Sciences, Inc. (CAI) Stock Forecast 2025 - AI Price Prediction & Analysis


Caris Life Sciences, Inc. (CAI) AI Stock Price Forecast & Investment Analysis

Caris Life Sciences, Inc. Stock Price Chart and Technical Analysis

Loading Caris Life Sciences, Inc. interactive price chart and technical analysis...

Caris Life Sciences, Inc. (CAI) - Comprehensive Stock Analysis & Investment Research

Deep dive into Caris Life Sciences, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Caris Life Sciences, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Caris Life Sciences, Inc.: Caris Life Sciences, Inc. operates in the Industrial Applications and Services sector, establishing it as a mid-cap growth opportunity.

Caris Life Sciences, Inc. (Stock Symbol: CAI) is a leading company in the Industrial Applications and Services sector , specifically operating within the Services-Medical Laboratories industry.

The organization employs approximately 99 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Caris Life Sciences, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Caris Life Sciences, Inc.: With $349M in annual revenue and 37.3% net margin, the company demonstrates exceptional profitability.

Annual Revenue: $349 million generating a 37.3% net profit margin .

Market Capitalization: $9574 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): 20.2% - Exceptional shareholder return efficiency, indicating strong management effectiveness.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Caris Life Sciences, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For Caris Life Sciences, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Caris Life Sciences, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Caris Life Sciences, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Caris Life Sciences, Inc.: Market positioning analysis based on available financial and operational metrics.

Caris Life Sciences, Inc. strategically competes in the highly dynamic Services-Medical Laboratories marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company maintains a healthy 49.8% gross margin, indicating strong pricing power and operational efficiency.

Caris Life Sciences, Inc. (CAI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Caris Life Sciences, Inc. stock analysis.

Loading Caris Life Sciences, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Caris Life Sciences, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Caris Life Sciences, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Caris Life Sciences, Inc.: With a P/E ratio of 7.55, the market sees the stock as potentially undervalued.

P/E Ratio 7.55x
P/B Ratio 21.14x
Market Cap $9574M
Dividend Yield 2.05%
EPS $7.42
Book Value/Share $1.61
Revenue/Share $19.39
FCF/Share $13.18
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Caris Life Sciences, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Caris Life Sciences, Inc.: An ROE of 20.2% demonstrates excellent shareholder value creation.

ROE 20.2%
ROA 4.1%
ROIC 4.5%
Gross Margin 49.8%
Operating Margin 38.8%
Net Margin 37.3%
EBT Margin 47.2%
Tax Rate 3.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Caris Life Sciences, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Caris Life Sciences, Inc.: A current ratio of 0.72 suggests potential liquidity concerns.

Current Ratio 0.72x
Quick Ratio 0.70x
D/E Ratio 3.01x
Financial Leverage 4.69x
Interest Coverage 3.6x
Working Capital $-106M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Caris Life Sciences, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Caris Life Sciences, Inc.: Free cash flow of $-654M indicates cash challenges that need attention.

Operating Cash Flow $338M
Free Cash Flow $-654M
Capital Spending $-992M
OCF Growth YoY 9.1%
FCF/Sales -187.4%
CapEx/Sales 284.4%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Caris Life Sciences, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Caris Life Sciences, Inc.: An asset turnover of 0.11x suggests room for improvement in asset utilization.

Asset Turnover 0.11x
Receivables Turnover 4.8x
Fixed Assets Turnover 0.2x
Days Sales Outstanding 77 days
Payables Period 8 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Caris Life Sciences, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Caris Life Sciences, Inc.: With annual revenue of $349M, Caris Life Sciences, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $349M
Operating Income $136M
Net Income $139M
SG&A Expense $11M
Cost of Goods Sold $50M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 7%
Cash & Short-term Investments 1%
Total Liabilities 75%
Short-term Debt 5%
Accounts Receivable 6%
Dividend & Shareholder Information
Dividends Per Share $1.15
Payout Ratio 13.5%
Shares Outstanding 281M

Latest Caris Life Sciences, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Caris Life Sciences, Inc. (CAI) stock price and investment outlook.

📰 We are currently updating our news feed for Caris Life Sciences, Inc.. Check back soon for the latest market analysis and company updates.

Caris Life Sciences, Inc. Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of Caris Life Sciences, Inc. against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACON Unlock Forecast - 30 Days FREE Trial $3M 0.0x 1.2x
ACONW Unlock Forecast - 30 Days FREE Trial $0M x 0.2x
ADVB Unlock Forecast - 30 Days FREE Trial $9M x 2.2x
AMS Unlock Forecast - 30 Days FREE Trial $16M 5.2x 0.7x
BDSX Unlock Forecast - 30 Days FREE Trial $65M -3.0x 56.8x
BGLC Unlock Forecast - 30 Days FREE Trial $76M x 9.8x
BNR Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
CAI Unlock Forecast - 30 Days FREE Trial $9574M 7.6x 21.1x
CDNA Unlock Forecast - 30 Days FREE Trial $757M 14.7x 2.3x
CELC Unlock Forecast - 30 Days FREE Trial $2469M -4.5x 55.7x
CSTL Unlock Forecast - 30 Days FREE Trial $621M -2110.5x 1.4x
DGX Unlock Forecast - 30 Days FREE Trial $20669M 21.8x 2.9x
EXAS Unlock Forecast - 30 Days FREE Trial $10207M -343.6x 4.1x
FLGT Unlock Forecast - 30 Days FREE Trial $680M 516.8x 0.6x
FTRE Unlock Forecast - 30 Days FREE Trial $929M -6.8x 1.6x
GH Unlock Forecast - 30 Days FREE Trial $6834M -8.9x -23.0x
GRAL Unlock Forecast - 30 Days FREE Trial $1393M x 0.6x
LH Unlock Forecast - 30 Days FREE Trial $23422M 30.7x 2.8x
NTRA Unlock Forecast - 30 Days FREE Trial $23045M -74.2x 18.5x
PMD Unlock Forecast - 30 Days FREE Trial $12M -5.7x 2.2x
PMDI Unlock Forecast - 30 Days FREE Trial $13M x 2.6x
PSNL Unlock Forecast - 30 Days FREE Trial $465M -2.3x 2.4x
RDNT Unlock Forecast - 30 Days FREE Trial $7027M 462.8x 7.5x
RENXF Unlock Forecast - 30 Days FREE Trial $10M x x
RNLXY Unlock Forecast - 30 Days FREE Trial $28M x x
SERA Unlock Forecast - 30 Days FREE Trial $152M -9.0x 1.7x
VCYT Unlock Forecast - 30 Days FREE Trial $2502M 95.0x 2.1x
XGN Unlock Forecast - 30 Days FREE Trial $213M -5.4x 10.1x

Frequently Asked Questions - Caris Life Sciences, Inc. Stock Forecast

How accurate are Caris Life Sciences, Inc. stock predictions?

Our AI model demonstrates 8500% historical accuracy for CAI predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence Caris Life Sciences, Inc. stock price forecasts?

Our analysis considers Caris Life Sciences, Inc.'s financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Caris Life Sciences, Inc. a good investment in 2025?

Based on our AI analysis, Caris Life Sciences, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Caris Life Sciences, Inc. forecasts updated?

Caris Life Sciences, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Caris Life Sciences, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Caris Life Sciences, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...